Mark Kaye is EVP & CFO of Elevance Health, Inc.. Currently has a direct ownership of 19,961 shares of ELV, which is worth approximately $8.26 Million. The most recent transaction as insider was on Mar 03, 2025, when has been sold 270 shares (Common Stock) at a price of $395.5 per share, resulting in proceeds of $106,785. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20K
1.25% 3M change
13.33% 12M change
Total Value Held $8.26 Million

Mark Kaye Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 03 2025
SELL
Payment of exercise price or tax liability
$106,785 $395.5 p/Share
270 Reduced 1.33%
19,961 Common Stock
Mar 03 2025
BUY
Grant, award, or other acquisition
-
3,604 Added 13.27%
23,565 Common Stock
Oct 02 2024
SELL
Payment of exercise price or tax liability
$1,423,540 $505.16 p/Share
2,818 Reduced 12.24%
20,213 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
2,755 Added 10.68%
23,031 Common Stock
Oct 02 2023
BUY
Grant, award, or other acquisition
-
20,276 Added 50.0%
20,276 Common Stock

Also insider at

MCO
MOODYS CORP Financial Services
CNMD
CONMED Corp Healthcare
MK

Mark Kaye

EVP & CFO
New York, NY

Track Institutional and Insider Activities on ELV

Follow Elevance Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELV shares.

Notify only if

Insider Trading

Get notified when an Elevance Health, Inc. insider buys or sells ELV shares.

Notify only if

News

Receive news related to Elevance Health, Inc.

Track Activities on ELV